NTN BUZZTIME INC Business Finance Contracts & Agreements
60 Contracts & Agreements
- Guaranty Agreements (1 contract)
- Investment Agreements (1)
- Loan Agreements (10)
- Note Agreements (7)
- Purchase Agreements (13)
- Registration Rights Agreements (10)
- Security Agreements (2)
- Stock Agreements (7)
- Subscription Agreements (1)
- Underwriting Agreements (1)
- Warrant Agreements (7)
- Form of Restricted Stock Unit Inducement Award for issuances under the Restated 2020 Plan (Filed With SEC on March 14, 2024)
- Form of Stock Option Inducement Award for issuances under the Restated 2020 Plan (Filed With SEC on March 14, 2024)
- Form of Restricted Stock Unit Inducement Award for issuances under the 2021 Inducement Plan (Filed With SEC on March 14, 2024)
- Form of Stock Option Inducement Award for issuances under the 2021 Inducement Plan (Filed With SEC on March 14, 2024)
- Registration Rights Agreement, dated as of December 14, 2023, by and among Eterna Therapeutics Inc. and the parties thereto (Filed With SEC on December 20, 2023)
- Securities Purchase Agreement, dated as of December 14, 2023, by and among Eterna Therapeutics Inc. and the purchasers party thereto (Filed With SEC on December 20, 2023)
- Form of Warrant (Filed With SEC on December 20, 2023)
- Form of 12.0% Senior Convertible Note (Filed With SEC on December 20, 2023)
- 6.0% Promissory Note, dated as of December 8, 2023, by and between Eterna Therapeutics Inc. and Charles Cherington (Filed With SEC on December 14, 2023)
- Registration Rights Agreement, dated as of July 13, 2023, by and among Eterna Therapeutics Inc. and the purchasers party thereto (Filed With SEC on July 18, 2023)
- Form of Common Stock Purchase Warrant (Filed With SEC on July 18, 2023)
- Form of Senior Convertible Note (Filed With SEC on July 18, 2023)
- Securities Purchase Agreement, dated as of July 13, 2023, by and among Eterna Therapeutics Inc. and the purchasers party thereto (Filed With SEC on July 18, 2023)
- Asset Purchase Agreement, dated April 26, 2023, by and among Eterna Therapeutics Inc., Exacis Biotherapeutics Inc., the stockholders party thereto and, with respect to certain... (Filed With SEC on May 2, 2023)
- Registration Rights Agreement, dated as of April 5, 2023, by and between Eterna Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 11, 2023)
- Purchase Agreement, dated as of April 5, 2023, by and between Eterna Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 11, 2023)
- Registration Rights Agreement, dated as of December 2, 2022, by and among Eterna Therapeutics Inc. and the purchasers party thereto (Filed With SEC on December 5, 2022)
- Form of Warrant (Filed With SEC on December 5, 2022)
- Registration Rights Agreement, dated as of March 6, 2022, between Brooklyn ImmunoTherapeutics, Inc. and the purchaser party thereto (Filed With SEC on March 9, 2022)
- Form of Common Stock Warrant (Filed With SEC on March 9, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on March 9, 2022)
- Securities Purchase Agreement, dated as of March 6, 2022, between Brooklyn ImmunoTherapeutics, Inc. and the purchaser party thereto (Filed With SEC on March 9, 2022)
- Registration Rights Agreement, dated as of July 16, 2021, by and among Brooklyn ImmunoTherapeutics, Inc. and the individuals and entities named therein (Filed With SEC on July 19, 2021)
- Registration Rights Agreement, dated as of May 26, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 26, 2021)
- Purchase Agreement, dated as of May 26, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 26, 2021)
- Specimen stock certificate evidencing shares of common stock of Brooklyn ImmunoTherapeutics, Inc (Filed With SEC on April 30, 2021)
- Registration Rights Agreement, dated as of April 26, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2021)
- Purchase Agreement, dated as of April 26, 2021, between Brooklyn ImmunoTherapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2021)
- 10% Promissory Note issued by NTN Buzztime, Inc. on January 12, 2021 (Filed With SEC on January 15, 2021)
- 10% Promissory Note to be issued by NTN Buzztime, Inc. on December 1, 2020 (Filed With SEC on November 23, 2020)
- Guaranty by Aram Fuchs in favor of NTN Buzztime, Inc (Filed With SEC on September 18, 2020)
- 8% Promissory Note issued by NTN Buzztime, Inc. on September 18, 2020 (Filed With SEC on September 18, 2020)
- Asset Purchase Agreement dated September 18, 2020 by and between NTN Buzztime, Inc. and eGames.com Holdings LLC (Filed With SEC on September 18, 2020)
- Second Amendment to Loan and Security Agreement dated June 1, 2020 between NTN Buzztime, Inc. and Avidbank (Filed With SEC on August 10, 2020)
- Acknowledgment and Agreement Regarding Loan Forgiveness dated April 18, 2020 (Filed With SEC on April 21, 2020)
- Paycheck Protection Program Note dated April 18, 2020 issued by NTN Buzztime, Inc. in favor of Level One Bank (Filed With SEC on April 21, 2020)
- First Amendment to Loan and Security Agreement dated as of March 12, 2020, between NTN Buzztime, Inc. and Avidbank (Filed With SEC on March 17, 2020)
- Asset purchase agreement dated January 13, 2020 between NTN Buzztime, Inc. and Sporcle, Inc (Filed With SEC on January 15, 2020)
- Loan and Security Agreement by and between Avid Bank and NTN Buzztime, Inc. dated September 28, 2018 (Filed With SEC on October 1, 2018)
- Form of Subscription Agreement, dated June 27, 2018, by and among NTN Buzztime, Inc. and the investor parties thereto (Filed With SEC on June 27, 2018)